Biological and Genetic Characteristics of Clinically Isolated Enterobacter cloacae with Multidrug Resistance.
- Author:
Jae Jung KIM
1
;
Sun Hoe KOO
Author Information
- Publication Type:Original Article
- Keywords: Enterobacter cloacae; Extended spectrum β lactamase; AmpC; Repetitive element sequence-based polymerase chain reaction; Multilocus sequence typing; Multidrug resistance
- MeSH: Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cloaca; Clone Cells; Drug Resistance, Multiple*; Enterobacter cloacae*; Enterobacter*; Korea; Methods; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction
- From:Laboratory Medicine Online 2018;8(3):99-106
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: From January 2014 to December 2015, 69 clones of Enterobacter cloacae showing multidrug resistance to six classes of antimicrobial agents were collected from two medical centers in Korea. METHODS: Minimum inhibitory concentrations were determined using the E-test method, and 17 genes were detected using polymerase chain reaction (PCR). The epidemiological relatedness of the strains was identified using repetitive element sequence-based PCR and multilocus sequence typing. RESULTS: The 69 E. cloacae clones produced extended spectrum β lactamase (ESBL) and AmpC and showed multidrug resistance to cefotaxime, ceftazidime, and aztreonam. We identified the following sequence types: ST56 of type VI for ESBL SHV (N=12, 17.4%); ST53, ST114, ST113, and ST550 of types I, IV, VI, and VII, respectively, for CTX-M (N=11, 15.9%); and ST668 of type III for the carbapenemase NDM gene (N=1, 1.5%). The AmpC DHA gene (N=2, 2.89%) was confirmed as ST134, although its type was not identified, whereas EBC (MIR/ACT; N=18, 26.1%) was identified as ST53, ST24, ST41, ST114, ST442, ST446, ST484, and ST550 of types V, I, III, IV, VII, and VI, respectively. The formed subclasses were bla CTX-M-3 and bla CTX-M-22 by CTX-M-1, bla CTX-M-9 and bla CTX-M-125 by CTX-M-9, bla DHA-1 by DHA, and bla MIR-7 and bla ACT-15,17,18,25,27,28 by EBC (MIR/ACT). CONCLUSIONS: There were no epidemiological relationships between the gene products and the occurrence of resistance among the strains.
